Categories: Technology

iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

 | Source: iRhythm

SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference.

iRhythm’s management is scheduled to present on Monday, January 12, 2026, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Events and Presentations” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Relations Contact
Stephanie Zhadkevich
investors@irhythmtech.com

Media Contact
Kassandra Perry
irhythm@highwirepr.com

GlobeNews Wire

Recent Posts

AGIBOT Hosts “AGIBOT NIGHT,” a Robot-Led Live Gala Show

A  Demonstration of Humanoid Robotics Operating at Scale in a Live Cultural SettingSHANGHAI, Feb. 8,…

3 hours ago

G42 and Vietnamese Consortium Commit to Build National AI Infrastructure and Develop Southeast Asia’s Intelligence Capacity

The FPT Corporation, the Viet Thai Group, and G42 sign Framework Agreement to advance Vietnam's digital…

6 hours ago

TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis

Campaign debuted during Super Bowl LX and introduced www.NextInMS.com, a new platform designed to create…

10 hours ago

R1 Appoints Andy Brailo as Chief Commercial Officer

February 06, 2026 11:00 ET  | Source: R1 RCM Holdco Inc. CHICAGO, Feb. 06, 2026…

10 hours ago

Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering

February 06, 2026 09:25 ET  | Source: Ernexa Therapeutics Inc. CAMBRIDGE, Mass., Feb. 06, 2026…

10 hours ago

/C O R R E C T I O N — Fairland Group – iGarden/

In the news release, "CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as…

13 hours ago